Thus, the above results indicate that YTHDF2 can mediate m6A-dependent mRNA decay to restrain LXRA and HIVEP2 expression under the activation of EGFR/SRC/ERK signaling in GBM cells. Here, YTHDF2 is linked to glioblastoma.